ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

CUE Cue Biopharma Inc

2.13
0.25 (13.30%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Cue Biopharma Inc CUE NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.25 13.30% 2.13 08:10:12
Open Price Low Price High Price Close Price Previous Close
1.90 1.87 2.19 2.13 1.88
more quote information »

Recent News

Date Time Source Heading
25/4/202400:01GLOBECue Biopharma to Present at the 2024 American Society of..
09/4/202406:05GLOBECue Biopharma Reports Fourth Quarter and Full Year 2023..
02/4/202423:00GLOBECue Biopharma to Host Business Update Call and Webcast
09/3/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202402:00GLOBECue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured..
23/2/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202400:00GLOBECue Biopharma to Present Corporate Update at the..
05/1/202408:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202300:00GLOBECue Biopharma to Present at the JMP Securities Hematology..
10/11/202308:05GLOBECue Biopharma Reports Third Quarter 2023 Financial Results..
08/11/202300:00GLOBECue Biopharma to Present at Three Upcoming Investor..
04/11/202307:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/11/202303:00GLOBECue Biopharma Presents New Positive Data from Phase 1 Trials..
02/11/202323:00GLOBECue Biopharma to Host Business Update Call and Webcast
27/9/202323:05GLOBECue Biopharma Announces Upcoming Scientific Presentations at..
26/9/202322:00GLOBECue Biopharma Announces Completion of Patient Enrollment in..
15/9/202306:01EDGAR2Form 8-K - Current report
30/8/202306:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202306:10GLOBECue Biopharma Reports Second Quarter 2023 Financial Results..
09/8/202306:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202322:00GLOBECue Biopharma to Host Business Update Call and Webcast
26/7/202302:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/7/202302:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/7/202302:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/7/202302:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202322:00GLOBECue Biopharma to Present at the Federation of Clinical..
07/6/202322:00GLOBECue Biopharma to Host Investor Call
05/6/202322:00GLOBECue Biopharma to Present at the Jefferies 2023 Global..
26/5/202307:00GLOBECue Biopharma Presents Positive Data Update from Ongoing..
15/5/202322:00GLOBECue Biopharma to Present at the 2023 American Society of..
10/5/202306:35GLOBECue Biopharma Reports First Quarter 2023 Financial Results..
08/5/202322:00GLOBECue Biopharma to Present at the Upcoming JMP Securities Life..

Your Recent History

Delayed Upgrade Clock